326 related articles for article (PubMed ID: 21784687)
1. Antiviral drug-associated potential vaccine-escape hepatitis B virus mutants in Turkish patients with chronic hepatitis B.
Sayan M; Akhan SC
Int J Infect Dis; 2011 Oct; 15(10):e722-6. PubMed ID: 21784687
[TBL] [Abstract][Full Text] [Related]
2. [HBV vaccine escape mutations in a chronic hepatitis B patient treated with nucleos(t)ide analogues].
Sayan M; Buğdacı MS
Mikrobiyol Bul; 2013 Jul; 47(3):544-9. PubMed ID: 23971933
[TBL] [Abstract][Full Text] [Related]
3. [HBV pol/S gene mutations in chronic hepatitis B patients receiving nucleoside/nucleotide analogues treatment].
Kırdar S; Yaşa MH; Sayan M; Aydın N
Mikrobiyol Bul; 2019 Apr; 53(2):144-155. PubMed ID: 31130119
[TBL] [Abstract][Full Text] [Related]
4. Monitoring of hepatitis B virus surface antigen escape mutations and concomitantly nucleos(t)ide analog resistance mutations in Turkish patients with chronic hepatitis B.
Sayan M; Sentürk O; Akhan SÇ; Hülagü S; Cekmen MB
Int J Infect Dis; 2010 Sep; 14 Suppl 3():e136-41. PubMed ID: 20382061
[TBL] [Abstract][Full Text] [Related]
5. Effect of HIV co-infection on mutation patterns of HBV in patients with lamivudine-resistant chronic hepatitis B.
Iacomi F; Vincenti D; Vairo F; Solmone M; Mariano A; Piselli P; Puro V; Capobianchi MR; Antonucci G
J Med Virol; 2009 Jul; 81(7):1151-6. PubMed ID: 19475624
[TBL] [Abstract][Full Text] [Related]
6. [Clinical characteristics and effect of secondary individualized therapy in chronic hepatitis B patients infected with the rtA181 mutation hepatitis B virus].
Ji FZ; Wang L; Yang BH; Zhao JJ; Liu F; Xue Y; Li T
Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):280-4. PubMed ID: 22964149
[TBL] [Abstract][Full Text] [Related]
7. Amino acid similarities and divergences in the small surface proteins of genotype C hepatitis B viruses between nucleos(t)ide analogue-naïve and lamivudine-treated patients with chronic hepatitis B.
Ding H; Liu B; Zhao C; Yang J; Yan C; Yan L; Zhuang H; Li T
Antiviral Res; 2014 Feb; 102():29-34. PubMed ID: 24316031
[TBL] [Abstract][Full Text] [Related]
8. Characterization of drug-resistance mutations in HBV D-genotype chronically infected patients, naïve to antiviral drugs.
Salpini R; Svicher V; Cento V; Gori C; Bertoli A; Scopelliti F; Micheli V; Cappiello T; Spanò A; Rizzardini G; De Sanctis GM; Sarrecchia C; Angelico M; Perno CF
Antiviral Res; 2011 Nov; 92(2):382-5. PubMed ID: 21920388
[TBL] [Abstract][Full Text] [Related]
9. Characterization of naturally occurring and Lamivudine-induced surface gene mutants of hepatitis B virus in patients with chronic hepatitis B in India.
Kazim SN; Sarin SK; Sharma BC; Khan LA; Hasnain SE
Intervirology; 2006; 49(3):152-60. PubMed ID: 16428891
[TBL] [Abstract][Full Text] [Related]
10. Characterization of hepatitis B virus genotypes/subgenotypes in 1,301 patients with chronic hepatitis B in North China.
Li XD; Wang L; Liu Y; Xu ZH; Dai JZ; Li L; Yao ZT; Xin SJ; Zhao JM; Xu DP
Chin Med J (Engl); 2011 Dec; 124(24):4178-83. PubMed ID: 22340383
[TBL] [Abstract][Full Text] [Related]
11. [The mutation patterns of HBV P gene and genotyping in patients with lanivudine-resistant chronic hepatitis B].
Tang JL; Zhou JK
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Oct; 25(5):342-4. PubMed ID: 22338219
[TBL] [Abstract][Full Text] [Related]
12. [Entecavir resistance in entecavir naive lamivudine treated chronic hepatitis B patients].
Sayan M; Hülagü S; Akhan SC; Sentürk O; Meriç M; Cekmen M
Mikrobiyol Bul; 2009 Jul; 43(3):425-32. PubMed ID: 19795617
[TBL] [Abstract][Full Text] [Related]
13. Naturally occurring amino-acid substitutions to nucleos(t)ide analogues in treatment naive Turkish patients with chronic hepatitis B.
Sayan M; Akhan SC; Meric M
J Viral Hepat; 2010 Jan; 17(1):23-7. PubMed ID: 19566788
[TBL] [Abstract][Full Text] [Related]
14. [Genotype distribution of chronic hepatitis B and hepatitis C patients and investigation of the resistance patterns in hepatitis B cases].
Kalayci R; Altindiş M; Gülamber G; Demirtürk N; Akcan Y; Demirdal T
Mikrobiyol Bul; 2010 Apr; 44(2):237-43. PubMed ID: 20549958
[TBL] [Abstract][Full Text] [Related]
15. Occult hepatitis B virus infection and lamivudine-resistant mutations in isolates from renal patients undergoing hemodialysis.
Motta JS; Mello FC; Lago BV; Perez RM; Gomes SA; Figueiredo FF
J Gastroenterol Hepatol; 2010 Jan; 25(1):101-6. PubMed ID: 19817965
[TBL] [Abstract][Full Text] [Related]
16. Molecular genesis of drug-resistant and vaccine-escape HBV mutants.
Locarnini SA; Yuen L
Antivir Ther; 2010; 15(3 Pt B):451-61. PubMed ID: 20516565
[TBL] [Abstract][Full Text] [Related]
17. Treatment of chronic hepatitis B virus infection - Dutch national guidelines.
Buster EH; van Erpecum KJ; Schalm SW; Zaaijer HL; Brouwer JT; Gelderblom HC; de Knegt RJ; Minke Bakker C; Reesink HW; Janssen HL;
Neth J Med; 2008; 66(7):292-306. PubMed ID: 18663260
[TBL] [Abstract][Full Text] [Related]
18. Antiviral resistance mutations potentiate hepatitis B virus immune evasion through disruption of its surface antigen a determinant.
Sloan RD; Ijaz S; Moore PL; Harrison TJ; Teo CG; Tedder RS
Antivir Ther; 2008; 13(3):439-47. PubMed ID: 18572757
[TBL] [Abstract][Full Text] [Related]
19. Evolution of hepatitis B virus polymerase gene mutations in hepatitis B e antigen-negative patients receiving lamivudine therapy.
Lok AS; Hussain M; Cursano C; Margotti M; Gramenzi A; Grazi GL; Jovine E; Benardi M; Andreone P
Hepatology; 2000 Nov; 32(5):1145-53. PubMed ID: 11050068
[TBL] [Abstract][Full Text] [Related]
20. Discrepancy of potential antiviral resistance mutation profiles within the HBV reverse transcriptase between nucleos(t)ide analogue-untreated and -treated patients with chronic hepatitis B in a hospital in China.
Li XG; Liu BM; Xu J; Liu XE; Ding H; Li T
J Med Virol; 2012 Feb; 84(2):207-16. PubMed ID: 22170539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]